ZA200804664B - Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt - Google Patents

Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt

Info

Publication number
ZA200804664B
ZA200804664B ZA200804664A ZA200804664A ZA200804664B ZA 200804664 B ZA200804664 B ZA 200804664B ZA 200804664 A ZA200804664 A ZA 200804664A ZA 200804664 A ZA200804664 A ZA 200804664A ZA 200804664 B ZA200804664 B ZA 200804664B
Authority
ZA
South Africa
Prior art keywords
pyrrol
fluorophenyl
dihydroxy
carbonyl
isopropyl
Prior art date
Application number
ZA200804664A
Other languages
English (en)
Inventor
Kaul Vijay
Yadav Gyan Chand
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of ZA200804664B publication Critical patent/ZA200804664B/xx

Links

ZA200804664A 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt ZA200804664B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2964DE2005 2005-11-08

Publications (1)

Publication Number Publication Date
ZA200804664B true ZA200804664B (en) 2009-04-29

Family

ID=40114304

Family Applications (3)

Application Number Title Priority Date Filing Date
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination
ZA200804665A ZA200804665B (en) 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
ZA200804664A ZA200804664B (en) 2005-11-08 2008-05-29 Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ZA200804666A ZA200804666B (en) 2005-11-08 2008-05-29 Pharmaceutical combination
ZA200804665A ZA200804665B (en) 2005-11-08 2008-05-29 Process for preparation of (3R, 5R)-7-[2-(4-fluorophenly)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

Country Status (2)

Country Link
CN (3) CN101304968A (xx)
ZA (3) ZA200804666B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102013157B1 (ko) * 2015-03-31 2019-08-23 대원제약주식회사 결정형 및 이의 제조방법
KR102218320B1 (ko) * 2019-07-12 2021-02-23 대원제약주식회사 (3r,5r)-7-(2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-((4-히드록시메틸페닐아미노)카보닐)-피롤-1-일)-3,5-디히드록시 헵탄산 헤미칼슘염의 제조방법, 및 이에 사용되는 중간체의 제조방법
CN111494369B (zh) * 2020-05-27 2022-07-01 上海市第五人民医院 一种用于冠心病的复方药物组合物
CN113143916A (zh) * 2021-04-28 2021-07-23 苏州大学 Batimastat在制备防治肥胖及继发骨丢失药物中的应用

Also Published As

Publication number Publication date
CN101304968A (zh) 2008-11-12
CN101304744A (zh) 2008-11-12
ZA200804665B (en) 2009-07-29
CN101304967B (zh) 2011-10-05
ZA200804666B (en) 2010-01-27
CN101304967A (zh) 2008-11-12

Similar Documents

Publication Publication Date Title
SG166829A1 (en) Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
ZA200806066B (en) Process for the preparation of 6,6-dimethyl-3-azabicyclo[3.1.0]-hexane compounds and enantiomeric salts thereof
ZA200804198B (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
ZA200705872B (en) Indole derivatives for treating viral infections
SMT201400142B (it) Composti di N-(1H-indazol-4-il) immidazo[1,2-A]piridin-3-carbossammide sostituita come inibitori di cfms
AP2007004128A0 (en) Tricyclic-nucleoside compounds for treating viral infections
PL1881976T3 (pl) Podstawione pochodne amidów jako inhibitory kinaz białkowych
ATE451363T1 (de) 3-(indazol-5-yl)-(1,2,4)triazinderivate und verwandte verbindungen als proteinkinaseinhibitoren zur behandlung von krebs
PL1882684T3 (pl) Pochodna pirolidyny albo jej sól
ATE447559T1 (de) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
GB2431927A9 (en) 1,2-Disubstituted indoles & derivatives thereof astherapeutic 5-iipoxygenase-activating protein (fl ap) inhibitors
EP1877055A4 (en) 4-AMINOQUINOLINE COMPOUNDS FOR THE TREATMENT OF VIRAL DISEASE CONDITIONS
TW200736195A (en) Methods for preparing sulfonamide substituted alcohols and intermediates thereof
PT1860098E (pt) Um novo derivado de ácido antranílico ou um seu sal
ZA200600495B (en) Method of treatment for improved bioavailability
IL184885A0 (en) 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension
DE602006019710D1 (de) Magnesiumsalze von hmg-coa-reduktase-hemmern
EP1926725A4 (en) PROTEIN KINASEINHIBITORS ON ALKOXYINDOLINONE BASE
ZA200804664B (en) Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2005123670A3 (en) Crystalline form of a substituted pyrrolidine compound
AP2007004270A0 (en) Process for preparing salts of hydrocyanic acid
FR2894596B1 (fr) Procede d'autocalibration de biopuces
WO2008010087A3 (en) Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
EP1971333A4 (en) AMINO ACID DERIVATIVES OF PROTEIN KINASE INHIBITORS ON INDOLINONE BASE